Introduction
Despite their shared genetic background, mice of the Igh a only CD8 ϩ T cells, always of donor origin (7), are necessary for suppression maintenance (3) Conversely, perinatal exposure of Igh a mice to the soluble form of IgG2a b allotype (but not to irrelevant Ig) induced full In this Ig-allotype-suppression system, cellular collaboration between the donor's anti-IgG2a b CD4 ϩ and CD8 ϩ T cells is and specific tolerance to this allotype (10) . In Igh a mice, T cell tolerance to IgG2a b is characterized in vivo by the required during the suppression-induction phase (5,6) but incapacity of the IgG2a b -primed T splenocytes to induce detection and quantification have been fully described elsewhere (11) . Briefly, the presence of serum IgG2a b was first IgG2a b suppression in Igh a/b recipients. We recently examined in detail the maintenance of this tolerance and showed that determined by immunoprecipitation in 1% agar-gel medium using a BALB/c anti-IgG2a b serum with a detection limit of this total unresponsiveness was, however, not definitively acquired but progressively reversed after IgG2a b clearance 5 µg/ml. The IgG2a b concentration was then measured, using anti-IgG2a b 5.7.2 mAb (27) , in an ELISA with a detection limit (11) . Even when Igh a mice were continuously exposed to the tolerogen from the perinatal period to 3 or 6 months of age, of 0.05 µg/ml. Using this ELISA, only mice with undetectable serum IgG2a b were considered to be subjected to supthe anti-IgG2a b T cell activity was restored 3 months after the end of tolerogen treatment. The course of tolerance reversion pression. was only slightly delayed when the tolerogen treatment was Preparation of the IgG2a b tolerogen and tolerance-induction prolonged in these mice until 9 months of age, when the procedure thymus showed marked but partial involution.
It had not been previously established whether this tolerThe mouse myeloma CBPC101 (IgG2a b ) cell line was a gift from Dr M. Potter (National Cancer Institute Contract N-01-ance induction was due to mechanisms of clonal deletion (12) (13) (14) (15) (16) , functional unresponsiveness (anergy) (17) (18) (19) or CB-71 085). The myeloma IgG2a b was semi-purified from ascitic fluid by 18% Na 2 SO 4 precipitation followed by gel active cell-mediated inhibition of specific clones (20) (21) (22) (23) . The systematic reversion of the T cell tolerance induced by filtration through Sepharose 6B. This semi-purified IgG2a b preparation, used for tolerance induction, was spun at 10,000 soluble IgG2a b in Igh a mice enabled these possibilities to be examined in the present investigation. To determine resr.p.m. and filtered through a 0.2 µm membrane, and therefore did not contain microaggregates. ponsibility, we followed two strategies: (i) prevention of de novo emergence of anti-IgG2a b T cells, in Igh a mice, by
The perinatal tolerogenesis consisted of in utero followed by post-natal exposure of Igh a mice to soluble IgG2a b . thymectomizing them at the end of tolerogen treatment, and (ii) long-term in vivo deposition of T splenocytes from tolerant This protocol was inspired by that applied to obtain B cell deprivation by perinatal administration of anti-IgM antibodies Igh a mice in an athymic tolerogen-free and histocompatible environment ['in vivo parking ' (24) (25) treatment in the presence of guinea pig serum as the source of C. Seven days after the injected, i.v., into 7-week-old BALB/c nu/nu mice. Reconstitution of their T cell compartment was followed by FACS analysis second injection, splenocytes from wild-type sensitized BALB/c mice were passed through nylon-wool columns (26) of their peripheral blood lymphocytes or splenocytes. to obtain a T lymphocyte-enriched population (Tsens). SplenomAb origin and FACS analysis cytes from normal or sensitized nu/nu mice were used without further treatment. The IgG2a b suppression-induction was FITC-conjugated anti-CD3ε mAb (29) The percentages shown here are those of 25-week-old recipients; they remained stable until the age of 34 weeks (last time point studied). n represents the number of Igh a/b recipients or untreated controls.
iodide -cells in a FACScan system (Becton Dickinson, when they reached 6 months of age. We also included two groups of tolerogen-untreated age-matched BALB/c mice: in Mountain View, CA) by using Cell Quest software.
the first, mice were thymectomized at the age of 6 weeks; in Statistical analysis the second, they were not thymectomized. All these mice were sensitized and the possible suppression-induction capacity of Statistical significance of percentage differences was detertheir Tsens was studied by transfer into Igh a/b F 1 . CD3 ϩ CD4 ϩ mined by χ 2 test. For mean comparison between, each time, and CD3 ϩ CD8 ϩ T subset percentages, determined by FACS two different groups, the significant equality of their variances analysis of splenocytes or Tsens from thymectomized or was first verified by fluctuation F-test (P Ͻ 0.05). The involved non-thymectomized IgG2a b -treated or IgG2a b -untreated Igh a means were then compared statistically by Student's t-test donors, were comparable (data not shown). As illustrated in (30) . (103.9 Ϯ 30.0 µg/ml) or that of recipients of Tsens from (Igh a/b ) newborns in which suppression induction and mainage-matched IgG2a b pn/Tx mice (71.2 Ϯ 33.1 µg/ml). As tenance were subsequently followed during adulthood. As determined by Student's t-test (P Ͻ 0.05), this latter mean shown in Table 1 , while Tsens from tolerogen-untreated indiwas only slightly but significantly lower than that of untreated viduals induced chronic suppression in 100% of their Igh a/b controls. In accordance with the suppression-induction inrecipients (n ϭ 30), Tsens from IgG2a b pn mice strongly and capacity or capacity of respectively IgG2a b pn/Tx or IgG2a b significantly [assessed using the χ 2 test (P Ͻ 0.05)] lost their untreated Tx mice, the sensitizing IgG2a bϩ B cells perfectly suppression-induction capacity, as they induced suppression engrafted and produced this allotype in the former but not in only in a maximum of 4.2% of their Igh a/b recipients (n ϭ 24). the latter (data not shown). This result shows that, in this experimental group, the T cell Consequently, these data demonstrated that the tolerance tolerance to IgG2a b was effectively established at the age of to IgG2a b became chronic in IgG2a b pn Igh a mice when de 3 months.
novo T cell maturation and differentiation were prevented by We then investigated the persistence of this perinatally thymectomy after the end of the tolerogen treatment. induced tolerance when the emergence of new T cells was Unresponsiveness of peripheral mature T cells is not reversed blocked, by thymectomizing the 6-week-old mice, 24 h after by long-term deposition in an athymic tolerogen-free the last injection of the soluble tolerogen. The anti-IgG2a b T environment cell suppression activity in these IgG2a b pn BALB/c mice either thymectomized since the age of 6 weeks (referred to
In parallel to thymectomy experiments, we studied the persistence of the induced tolerance to IgG2a b in a T cell population as IgG2a b pn/Tx) or non-thymectomized was then studied Individual FACS analyses were performed on PBL (16 weeks) and on splenocytes (20 weeks) after T cell transfers into 7-week-old nu/nu BALB/c mice. n represents the number of mice studied. PBL, peripheral blood mononuclear cells. transferred into tolerogen-free, T cell-deficient mice (in vivo of untreated wild-type BALB/c mice, the CD3 ϩ CD4 ϩ and CD3 ϩ CD8 ϩ compartment reconstitutions, with T splenocytes parking strategy). nu/nu Igh a BALB/c mice provide a syngenic and IgG2a b -free environment for long-term in vivo deposition from normal or IgG2a b pn Igh a mice, were significantly similar to one another [Student's t-test (P Ͻ 0.05)] and each was of normal or tolerant Igh a T cells. At the end of tolerogen treatment, i.e. at the age of 6 weeks, 5ϫ10 7 T cell-enriched markedly higher than that of unreconstituted nu/nu controls. Twenty weeks after the T cell transfers, the possible antisplenocytes from normal or IgG2a b pn mice were transferred into 7-week-old nu/nu BALB/c depositary mice. The repopuIgG2a b T cell activity of in vivo parked T cells was investigated. Untreated or T cell-reconstituted nu/nu mice were sensitized lation of the T compartments of these nu/nu mice was followed by FACS studies of their peripheral blood lymphocytes, 16 and their suppression-induction capacity was evaluated by transfer of their splenocytes into Igh a/b newborns. To apply a weeks later, and of their splenocytes, 20 weeks later. As shown in Table 2 , although these T subset repopulations were transplantation protocol, as homogeneous as possible to our usual regimen, 5ϫ10 7 total splenocytes from non-reconstipartial and the T cell percentages did not attain those lysis because the unresponsiveness persisted in mature T splenocytes from IgG2a b pn Igh a mice throughout long-term recipients (n ϭ 24). This observation is in very good agreement with our earlier finding that this allotype suppression was (20 weeks) in vivo deposition in an athymic tolerogen-free environment. indeed T cell induced. Upon sensitization, normal Igh a T cells, parked for 20 weeks in nu/nu mice, were able to induce suppression in 100% of their Igh a/b recipients (n ϭ 9), while Discussion T cells from tolerant IgG2a b pn Igh a mice, parked under the same conditions, remained highly significantly [assessed Over the last few years, experimental animal models of specific T cell-tolerance induction and antigen-specific using the χ 2 test (P Ͻ 0.05)] tolerant to IgG2a b and induced suppression in only 9.1% of their Igh a/b recipients (n ϭ 11).
immunotherapy have essentially used TCR transgenic mice (14, (32) (33) (34) or superantigenic T cell responses (12, 13, 35) . The mean IgG2a b concentration in Igh a/b recipients of in vivo parked normal T cells was 0.00 Ϯ 0.00 µg/ml and of In this present study, the in vivo T cell-induced IgG2a bsuppression system (reviewed in 4) was exploited, as a course drastically lower than that in recipients of in vivo parked tolerant T cells (53.4 Ϯ 35.0 µg/ml). As analyzed using physiological model, to investigate the mechanisms of the full and specific T cell tolerance to IgG2a b , and its systematic Student's t-test (P Ͻ 0.05), the mean IgG2a b concentration in these latter was slightly but significantly lower than that in reversion in mice of the Igh a haplotype, perinatally exposed to soluble IgG2a b . This model has been developed based on Igh a/b recipients of splenocytes from non-reconstituted nu/nu mice (92.2 Ϯ 30.4 µg/ml). These events are reminiscent of the existence, in untreated normal Igh a mice, of an intrinsic T cell activity against the expression of IgG2a from the Igh b those of recipients of Tsens from 6-month-old Igh a IgG2a b pn/Tx mice (Fig. 1) The in vitro T cell proliferation in response to anti-TCR V β mAb, intensely inhibited by in vivo less, this T cell tolerance is progressively reversed with tolerogen clearance, i.e. within 3 months after the end of superantigen-induced anergy, was totally restored after 3 weeks of parking in superantigen-free mice (24) . (ii) Anti-H-Y IgG2a b administration. Furthermore, the acquired tolerance was not definitive, even when the exposure to tolerogen was TCR transgenic CD8 ϩ T cells, anergized in male nu/nu recipients by a TCR-CD8 down-regulation mechanism (37), prolonged to 9 months of age (11) . Here, we shed some light on the mechanisms of induction and reversion of this regained in vivo proliferative capacity when parked for 8 weeks in syngenic nu/nu females (38) . (iii) Inhibition of the tolerance. Perinatal exposure of Igh a BALB/c mice to soluble IgG2a b followed by thymectomy, after the end of tolerogen conventional helper CD4 ϩ T cell response to viral antigen in antigen transgenic mice was also rapidly abrogated after a treatment, resulted in definitive acquisition of tolerance. Indeed, the systematic re-establishment of anti-IgG2a b T cell 1-week incubation of their T splenocytes in their non-transgenic SCID counterparts (39) . (iv) The kinetics of peripheral activity was effectively inhibited by preventing de novo T cell differentiation and maturation. It is noteworthy that, by tolerance induced by staphylococcal enterotoxin B superantigen in CD4 ϩ V β 8 ϩ T cells also showed an in vivo anergy thymectomy 1 day after the last tolerogen injection at 6 weeks of age, we deliberately chose to investigate the reversibility reversion 12 weeks after the end of tolerogen treatment (40) .
Only the tolerance of CD4 ϩ T cells to Mls-mismatched boneof tolerance in the T cells exposed to the high levels of circulating tolerogen. It will be interesting to study, with this marrow grafts, involving peripheral anergy, was not reversed in hosts; however, in this case, the established grafts acted strategy, the behaviour of T cells, generated throughout the period of progressive decrease of tolerogen concentrations, plausibly as a continuous source of tolerogen (41) . It is highly unlikely that the recruitment of T lymphocytes e.g. at the age of 3 months. Nevertheless, in the latter case the distinction between individuals always subjected to that would actively maintain tolerance in T cells (23) could be involved in our system. Indeed, it is difficult to conceive that tolerance to those having already reversed it will oblige us to carry out individual (rather than pool) Tsens transfers. hypothesis of definitive tolerance persistence by the action of these possible antigen-presenting cells can be discarded. T cells and not reversible anergy mechanisms. The reversion of tolerance is directly due to the emergence of new antiIndeed, these latter might be capable of maintaining tolerance in IgG2a b pn Igh a donors. Conversely, the total but temporary IgG2a b T cells, migrating to peripheral lymphoid organs, as long as the thymus remains functional. We previously absence of an anti-IgG2a b T cell response could be the effect of transient exhaustion of anti-IgG2a b T cells (42) (43) (44) . Indeed, observed that the thymus involution, assessed by the cellularity of this organ, at least in the BALB/c mice we studied, it is quite possible, if the anti-IgG2a b T cells were able to leave the thymus, that the almost simultaneous activation was not complete even at 15 months of age and that the antiIgG2a b T cell activity could still be recovered in Igh a mice and differentiation of all available anti-IgG2a b T cells into suppression inducers or effectors, upon repeated IgG2a b exposed to IgG2a b from the perinatal period to 9 months of age (last time point studied) (11) . Despite severe thymus size administrations, were followed by their total simultaneous disappearance by activation-induced cell death. Tolerance reduction and slowing down of T cell export with ageing, the thymic output of 24-month-old mice has been estimated to breakdown and re-establishment of the suppression-induction capacity would then be always possible by a still dynamic be reduced to 0.7% (but not 0.0%) of that of newborns (36) . On the other hand, the expression of the basic anti-IgG2a b T thymic output after tolerogen clearance.
In Igh a/b mice, transgenic for a certain MHC class IIcell activity in normal Igh a mice could suggest the existence of a particularly high incidence of V α J α /V β DJ β TCR gene restricted anti-IgG2a b TCR, CD4 ϩ CD8 ϩ double-positive thymocytes are not deleted, the mature CD4 ϩ transgenic T rearrangement for this specificity. The resultant high frequency of anti-IgG2a b T cell resurgence would then still allow the cells do not become tolerant at the periphery and the IgG2a b is subjected to an apparent CD8 ϩ -independent suppression breakdown of tolerance to IgG2a b in aged Igh a mice, despite the reduction of their thymic output, as soon as the tolerogen (45) . This example moves far from the physiological situation, i.e. CB20 and C57BL/6 Igh b mice which are naturally tolerant disappeared. Surely this resurgence also participates in the normal turnover of these T cells.
to was also demonstrated upon their exposure to increasing amounts of the Igλ 2 315 idiotype secreted by implanted MOPC315 plasmacytoma cells (48) .
Abbreviations It is noteworthy, as we described elsewhere (11) , that even when we introduced high levels of IgG2a b to induce T cell Therefore, it cannot be excluded that a minority of specific T 6 Majlessi, L., Benaroch, P., Denoyelle, C. and Bordenave, G. 1993. clones, e.g. of low affinity (49) or specific to non-dominant 
